Mac Process and Schenck AccuRate To Merge and Be Renamed - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Mac Process and Schenck AccuRate To Merge and Be Renamed



Mac Process, a supplier of pneumatic conveying and air-filtration systems, and Schenck AccuRate, a leader in the manufacture and supply of dry material feeders and weighing technologies, have merged. Both companies are part of the global Schenck Process Group and have integrated their operations in North America under the name Schenck Process.

Manufacturing for Schenck Process will continue in Whitewater, WI and Sabetha, KS and the company headquarters will be located in Kansas City, MO. Integration efforts began in 2012, resulting in streamlined processes between the two operations, which provide pneumatic conveying, filtration, weighing, and feeding systems from one supplier.

Source: Mac Process

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here